LEN vs LEN-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Lennar exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a defensive valuation below its Graham Number of $117.86. However, this financial stability is starkly contrasted by a severe operational collapse, evidenced by a -52.60% YoY earnings decline and a 0/4 earnings beat record over the last four quarters. While the balance sheet is a fortress with a Debt/Equity ratio of 0.25 and a Current Ratio of 8.33, the technical trend is completely bearish (0/100). The stock is currently caught between strong solvency and deteriorating growth fundamentals.
Lennar Corporation exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity 0.25). While the stock is significantly undervalued relative to its Graham Number ($117.86), it is currently plagued by severe fundamental deterioration, with earnings plummeting over 50% YoY. The disconnect between strong solvency and crashing growth, coupled with a 0/100 technical trend, suggests a value trap scenario in the short term despite long-term defensive viability.
Compare Another Pair
Related Comparisons
LEN vs LEN-B: Head-to-Head Comparison
This page compares Lennar Corporation (LEN) and Lennar Corporation (LEN-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.